Cite
Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients.
MLA
Sørensen, Patricia, et al. “Serum HER-2: Sensitivity, Specificity, and Predictive Values for Detecting Metastatic Recurrence in Breast Cancer Patients.” Journal of Cancer Research & Clinical Oncology, vol. 139, no. 6, June 2013, pp. 1005–13. EBSCOhost, https://doi.org/10.1007/s00432-013-1411-7.
APA
Sørensen, P., Jakobsen, E., Madsen, J., Petersen, E., Andersen, R., Østergaard, B., & Brandslund, I. (2013). Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients. Journal of Cancer Research & Clinical Oncology, 139(6), 1005–1013. https://doi.org/10.1007/s00432-013-1411-7
Chicago
Sørensen, Patricia, Erik Jakobsen, Jonna Madsen, Eva Petersen, Rikke Andersen, Birthe Østergaard, and Ivan Brandslund. 2013. “Serum HER-2: Sensitivity, Specificity, and Predictive Values for Detecting Metastatic Recurrence in Breast Cancer Patients.” Journal of Cancer Research & Clinical Oncology 139 (6): 1005–13. doi:10.1007/s00432-013-1411-7.